Clinical Trials

Search for actively enrolling clinical trials

AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Study ID: STU 122014-044

Summary

See protocol/CiRB application

Participant Eligibility

See protocol

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
Tamra Lynn Slone

Contact:

Lindsay Therrian

Lindsay.Therrian@childrens.com

Linked In Email
scroll to top